Skip to Main content Skip to Navigation
Journal articles

Effect of mass dihydroartemisinin–piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance

Himanshu Gupta 1, 2 Beatriz Galatas 1, 2, 3 Arlindo Chidimatembue 3 Silvie Huijben 1, 2 Pau Cisteró 1, 2 Gloria Matambisso 3 Lidia Nhamussua 3 Wilson Simone 3 Quique Bassat 1, 2, 3, 4, 5, 6 Didier Menard 7 Pascal Ringwald 8 N. Regina Rabinovich 1, 2, 9 Pedro Alonso 1, 2, 3 Francisco Saúte 3 Pedro Aide 3, 10 Alfredo Mayor 1, 2, 3, 4, *
* Corresponding author
1 ISGlobal - Instituto de Salud Global - Institute For Global Health [Barcelona]
2 UB - Universitat de Barcelona
3 CISM - Centro de Investigação em Saúde de Manhiça [Maputo, Mozambique]
4 ICREA - Institució Catalana de Recerca i Estudis Avançats
5 CIBER de Epidemiología y Salud Pública (CIBERESP)
6 Hospital Sant Joan de Déu [Barcelona]
7 Biologie des Interactions Hôte-Parasite - Biology of Host-Parasite Interactions
8 WHO - World Health Organisation
9 Harvard T.H. Chan School of Public Health
10 National Institute of Health Mozambique
Abstract : Background Mass drug administration (MDA) can rapidly reduce the burden of Plasmodium falciparum (Pf). However, concerns remain about its contribution to select for antimalarial drug resistance. Methods We used Sanger sequencing and real-time PCR to determine the proportion of molecular markers associated with antimalarial resistance (k13, pfpm2, pfmdr1 and pfcrt) in Pf isolates collected before (n = 99) and after (n = 112) the implementation of two monthly MDA rounds with dihydroartemisinin–piperaquine (DHAp) for two consecutive years in Magude district of Southern Mozambique. Results None of the k13 polymorphisms associated with artemisinin resistance were observed in the Pf isolates analyzed. The proportion of Pf isolates with multiple copies of pfpm2, an amplification associated with piperaquine resistance, was similar in pre- (4.9%) and post-MDA groups (3.4%; p = 1.000). No statistically significant differences were observed between pre- and post-MDA groups in the proportion of Pf isolates neither with mutations in pfcrt and pfmdr1 genes, nor with the carriage of pfmdr1 multiple copies (p>0.05). Conclusions This study does not show any evidence of increased frequency of molecular makers of antimalarial resistance after MDA with DHAp in southern Mozambique where markers of antimalarial resistance were absent or low at the beginning of the intervention.
Document type :
Journal articles
Complete list of metadata
https://hal-pasteur.archives-ouvertes.fr/pasteur-03274274
Contributor : Didier Menard Connect in order to contact the contributor
Submitted on : Tuesday, June 29, 2021 - 9:55:17 PM
Last modification on : Tuesday, October 19, 2021 - 10:29:31 PM
Long-term archiving on: : Thursday, September 30, 2021 - 7:25:24 PM

File

Vignette du document
pone.0240174.pdf
Publication funded by an institution

Licence

Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

PASTEUR | CNRS

Citation

Himanshu Gupta, Beatriz Galatas, Arlindo Chidimatembue, Silvie Huijben, Pau Cisteró, et al.. Effect of mass dihydroartemisinin–piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance. PLoS ONE, Public Library of Science, 2020, 15 (10), pp.e0240174. ⟨10.1371/journal.pone.0240174⟩. ⟨pasteur-03274274⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

7

Files downloads

7